Dr Reddy's Laboratories Ltd is India’s top multinational pharmaceutical companies. Headquartered in Hyderabad, with U.S. operations in New Jersey, the company manufactures over 190 medications, 60 active pharmaceutical ingredients (APIs), diagnostic kits, and biotechnology products. Founded by Kallam Anji Reddy, it started as a supplier to Indian drug makers and gradually expanded into global markets. Approval in regulated markets like the U.S. and Europe strengthened its growth which is also reflected in Dr Reddy's Laboratories Ltd share price.

History of Dr Reddy's Laboratories Ltd Share Price

Founded in 1984, Dr Reddy's began with active pharmaceutical ingredients and soon launched branded drugs like Norilet and Omez. By 1987, it became the first Indian company to export APIs to Europe. Expansion into regulated markets, FDA-approved plants, and diversified products contributed to consistent growth, shaping Dr Reddy's Laboratories Ltd share price over the years.

Financial Performance of Dr. Reddy’s Laboratories

Dr Reddy share price reflects the performance of one of India’s leading pharmaceutical companies. As of today, Dr Reddy share price on NSE and BSE shows the market’s response to the company’s steady growth. The company has reported strong revenue and healthy operating margins, supporting investor confidence.

Revenue & Profit: Q3 FY26 revenue rose 4.4% YoY to ₹87.3 billion, while net profit fell 14% to ₹12.1 billion due to pricing pressures.

Margins & Efficiency: EBITDA margin remains high at 28.3%; cash conversion cycle is 36 days.

Debt: Total debt stood at ₹60.36 billion.

Growth Drivers: Investments in biosimilars, oncology, new product launches, and strategic partnerships continue to boost Dr Reddy’s laboratories share price.

Investors tracking Dr Reddy share price today can consider its consistent financial performance and long-term growth potential on both the NSE and BSE.

Business Segments of DR. Reddy’s Laboratories Ltd 

Dr. Reddy’s Laboratories Ltd operates through key business segments that drive growth.

Global Generics (GG): Core segment producing prescription and OTC medicines, biosimilars, and branded generics. Major markets include the USA, India, Russia, and Europe.

Pharmaceutical Services and Active Ingredients (PSAI): Focuses on manufacturing APIs and intermediates, including services through Aurigene Pharmaceutical Services (APSL) for drug discovery and development.

Proprietary Products & Others: Covers niche formulations, new chemical entities, and digital health products.

Other Initiatives: Expansion into consumer health, nutrition, and advanced technologies like cell and gene therapy.

These segments together help maintain steady revenue growth and support Dr Reddy share price today.

Subsidiaries of  Dr. Reddy’s Laboratories Ltd 

Dr. Reddy’s Laboratories Ltd operates through a wide global network of over 50 subsidiaries, supporting its growth and influencing Dr Reddy share price BSE.

Key International Subsidiaries

USA: Dr. Reddy's Laboratories Inc., Trigenesis Therapeutics, Inc.

Europe: Dr. Reddy's Laboratories (EU) Limited (UK), betapharm Arzneimittel GmbH (Germany), Dr. Reddy's Laboratories Romania SRL

Emerging Markets: Dr. Reddy's Farmaceutica Do Brasil Ltda (Brazil), Dr. Reddy's Laboratories (Proprietary) Ltd (South Africa), Dr. Reddy's Laboratories (Thailand) Ltd

Other Regions: Dr. Reddy's Laboratories Canada, Inc., Dr. Reddy's Laboratories (Australia) Pty. Limited

Notable Subsidiaries: Aurigene Discovery Technologies, Idea2Enterprises (India) Private Limited

This global presence helps Dr. Reddy’s maintain revenue growth and strengthens Dr Reddy share price. The performance of each division and the company’s other strategic actions help drive Dr Reddy share price NSE and BSE performance, reflecting the company’s consistent growth and investor confidence.

History of Dr Reddy's Laboratories Ltd Share Price

Financial Performance of Dr. Reddy’s Laboratories

Business Segments of DR. Reddy’s Laboratories Ltd

Subsidiaries of Dr. Reddy’s Laboratories Ltd

Business Segments of DR. Reddy’s Laboratories Ltd 

Subsidiaries of  Dr. Reddy’s Laboratories Ltd 

Dr Reddys Laboratories Ltd

DRREDDY Share Price